• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Biogen CEO sees progress in launch of Alzheimer’s drug Leqembi

cafead

Administrator
Staff member
  • cafead   Jan 08, 2024 at 10:32: PM
via At the J.P. Morgan Healthcare Conference Monday, company head Chris Viehbacher said insurance reimbursement is now ‘not an issue’ for treatment.

article source
 

<